SIROLIMUS, an anti-organ rejection drug, called “Rapamycin is shown to increase longevity by inhibiting the target of rapamycin kinase (TOR). Study systems including yeast, nematodes, flies, and mammals, have shown that reduction of TOR signaling will result in an increased life span.”
http://en.m.wikipedia.org/wiki/Life_extension
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022